Objective: Analyze the impact of confinement due to the global and health crisis of COVID-19 on an applicant for international protection with low vision Methods: For data collection, the role list, ...MOHOST registration and a semi-structured interview adapted to know the impact of occupations during confinement have been used. Conclusion: The results obtained indicate that the user has maintained optimal occupational performance although many of the occupations have been affected by the confinement caused by COVID-19. However, the user has carried out a routine regarding personal self-care, health maintenance, and leisure activities such as reading and academics such as language study. It is necessary to highlight the role of Occupational Therapy in this group, since it allows understanding the occupational needs of the person and the environment, promoting participation in occupations in a balanced way and according to the reality of the moment.
Objetivos: Analizar el impacto del confinamiento debido a la crisis sanitaria y mundial del COVID-19 en una persona solicitante de protección internacional con baja visión. Métodos: para la recogida de datos se utilizó el listado de roles, el registro de MOHOST y una entrevista semiestructurada adaptada para conocer el impacto de las ocupaciones durante el confinamiento. Conclusión: los resultados obtenidos indicaron que el usuario mantuvo un desempeño ocupacional óptimo aunque muchas de las ocupaciones se vieron afectadas por el confinamiento causado por el COVID-19. Aun así, el usuario llevó a cabo una rutina en lo referente al autocuidado personal, mantenimiento de la salud, actividades de ocio como la lectura y de tipo académico como el estudio de idiomas. Es necesario destacar el rol de la Terapia Ocupacional en este colectivo, ya que permite entender las necesidades ocupacionales de la persona y el entorno, promoviendo la participación en ocupaciones de manera equilibrada y acorde a la realidad del momento.
Background
The long‐term sequalae of COVID‐19 remain poorly characterized. We assessed persistent symptoms in previously hospitalized patients with COVID‐19 and assessed potential risk factors.
...Methods
Data were collected from patients discharged from 4 hospitals in Moscow, Russia between 8 April and 10 July 2020. Participants were interviewed via telephone using an ISARIC Long‐term Follow‐up Study questionnaire.
Results
2,649 of 4755 (56%) discharged patients were successfully evaluated, at median 218 (IQR 200, 236) days post‐discharge. COVID‐19 diagnosis was clinical in 1291 and molecular in 1358. Most cases were mild, but 902 (34%) required supplemental oxygen and 68 (2.6%) needed ventilatory support. Median age was 56 years (IQR 46, 66) and 1,353 (51.1%) were women. Persistent symptoms were reported by 1247 (47.1%) participants, with fatigue (21.2%), shortness of breath (14.5%) and forgetfulness (9.1%) the most common symptoms and chronic fatigue (25%) and respiratory (17.2%) the most common symptom categories. Female sex was associated with any persistent symptom category OR 1.83 (95% CI 1.55 to 2.17) with association being strongest for dermatological (3.26, 2.36 to 4.57) symptoms. Asthma and chronic pulmonary disease were not associated with persistent symptoms overall, but asthma was associated with neurological (1.95, 1.25 to 2.98) and mood and behavioural changes (2.02, 1.24 to 3.18), and chronic pulmonary disease was associated with chronic fatigue (1.68, 1.21 to 2.32).
Conclusions
Almost half of adults admitted to hospital due to COVID‐19 reported persistent symptoms 6 to 8 months after discharge. Fatigue and respiratory symptoms were most common, and female sex was associated with persistent symptoms.
Word cloud showing persistent symptoms 6–8 months since hospital discharge in people previously hospitalised with COVID‐19.
"COVID" terminology in dermatology Gaurav, Vishal; Grover, Chander
Indian journal of dermatology,
11/2021, Letnik:
66, Številka:
6
Journal Article
Recenzirano
Odprti dostop
Ever since the beginning of COVID-19 pandemic, mucocutaneous manifestations started being noticed and are still being documented. Many of these have been described with the prefix "COVID" and may ...occur due to the infection (e.g., COVID rash), use of personal protective equipment in healthcare workers (e.g., COVID hand dermatitis) or extensive use of novel vaccines (e.g., COVID arm). This article attempts to summarize such entities with clinical relevance to dermatologists and physicians in general and to create awareness about this fast-evolving COVID lexicon.
Post recovery manifestations have become another concern in patients who have recovered from coronavirus disease 2019 (COVID‐19). Numerous reports have shown that COVID‐19 has a variety of long‐term ...effects on almost all systems including respiratory, cardiovascular, gastrointestinal, neurological, psychiatric, and dermatological systems. We aimed to investigate the prevalence and characteristics of the post‐COVID syndrome among COVID‐19 survivors and to determine the factors associated with persistent symptoms. This prospective study enrolled in patients with COVID‐19 followed in hospital or outpatient clinics in Ankara City Hospital. We performed a special questionnaire to inquire about the presence of persistent symptoms beyond 12 weeks from the first diagnosis. Demographic data, comorbid diseases, characteristics of acute COVID‐19, presence of persistent symptoms by systems, and knowledge about outpatient clinic visits after recovery were assessed. Of a total of 1007 participants, 39.0% had at least one comorbidity, and 47.5% had persistent symptoms. Fatigue/easy fatigability, myalgia, and loss of weight were the most frequent persistent symptoms (overall 29.3%) followed by respiratory symptoms (25.4%). A total of 235 participants had visited outpatient clinics due to several reasons during the post‐COVID‐19 period, and 17 of them were hospitalized. Severe acute COVID‐19, hospitalization, and presence of comorbidity were independent factors for the development of persistent symptoms. Fully understanding the spectrum of the post‐COVID syndrome is essential for appropriate management of all its long‐term effects. Our study once again underlined the fact that the prevalence of post‐COVID syndrome is higher than expected and concerns many systems, and a multidisciplinary follow‐up should be provided to COVID‐19 survivors in the post recovery period.
Highlights
COVID‐19 has a variety of long‐term effects on almost all systems.
Respiratory, cardiovascular, gastrointestinal, neurological, psychiatric, and dermatological systems are affected in different degree.
We detected the prevalence of the post?COVID syndrome among COVID‐19 survivors as 47.5% on 1007 participant.
Fatigue/easy fatigability, myalgia, and loss of weight were the most frequent persistent symptoms (overall 29.3%), and followed by respiratory symptoms (25.4%).
Severe acute COVID‐19, hospitalization, and presence of comorbidity were independent factors for the development of persistent symptoms.
PDF
